Recombinant 4-1BB (Utomilumab Biosimilar) anticorps

N° du produit ABIN7538049

L’anticorps Human Monoclonal anti-4-1BB (Utomilumab Biosimilar) a été validé pour ELISA et WB. Il convient pour détecter 4-1BB (Utomilumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant 4-1BB (Utomilumab Biosimilar) anticorps (ABIN7538049)

Antigène: 4-1BB (Utomilumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp 4-1BB (Utomilumab Biosimilar) est non-conjugé

Application: ELISA, Western Blotting (WB)

Classe de qualité: Research Grade

Détail du produit anti-4-1BB (Utomilumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Utomilumab Biosimilar - Anti-Human TNFRSF9 mAb - Research Grade

Attributs du produit: Antibody Type: IgG2 kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Pureté: > 85%

Isotype: IgG2

Information d'application

Restrictions: For Research Use only

Stockage

Buffer: PBS pH 7.5

Stock: 4 °C,-20 °C

Stockage commentaire: 4°C for short term, -20°C for long term

Détails sur 4-1BB (Utomilumab Biosimilar)

Antigène: 4-1BB (Utomilumab Biosimilar)

Sujet: Utomilumab is a monoclonal antibody that binds to 4-IBB protein (also known as CD137 protein). 4-IBB protein is a receptor found in different immune cells such as helper T-cells, killer T-cells and natural killer cells. 4-IBB/CD137 protein is a costimulatory receptor whose activation results in a series of events that leads to cytokine secretion and effector functions. Hence, targeting CD137 protein has been linked to antitumor immunity response and overall tumor reduction. Indeed, once utomilumab is injected in the bloodstream its specific binding to CD137 protein stimulates the immune cells which, as a result, enhances the immune response against tumors.

Numéro CAS: 1417318-27-4